Projects overview

Sort by

Toggle all information

VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa

01-06-2019

-

31-03-2026

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SC1-2018-Two-Stage-RTD
SC1-BHC-15-2018 New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)

HELP | Collaboration for innovation: Establishment of a pan-nematode drug development platform

01-09-2019

-

28-02-2026

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SC1-2018-Two-Stage-RTD
SC1-BHC-15-2018 New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)

TT4CL | Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

01-05-2019

-

31-07-2024

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SC1-2018-Two-Stage-RTD
SC1-BHC-15-2018 New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)

Vacc-iNTS | Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa

01-10-2019

-

31-07-2026

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SC1-2018-Two-Stage-RTD
SC1-BHC-15-2018 New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)

SHIGETECVAX | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea

01-09-2019

-

28-02-2025

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SC1-2018-Two-Stage-RTD
SC1-BHC-15-2018 New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
Powered by Chris Decubber BV